TD

Tim Drager

Partner at Brighton Park Capital

New York City Metropolitan Area

Overview 

Tim Drager is a Partner at Brighton Park Capital in the New York City Metropolitan Area, with a background in financial economics and extensive experience working with notable companies like PortSwigger and DataVisor. He has held board positions and made investments in various organizations, specializing in Series B funding for Real Estate/PropTech sectors in New York City.

Work Experience 

  • Partner

    2019 - Current

    Brighton Park is an investment firm that specializes in software, information services, and technology-enabled services. We partner with exceptional management teams and use our decades of operating experience to help them build world class companies. We help our companies attract unique talent, develop market-leading products, build highly productive sales organizations, and connect better with customers through the use of technology.

Brighton Park Capital is an investment firm that specializes in software, information services, and technology-enabled services.

  • Board Member

    2024

    Web Application Security

  • Board Observer

    2023

    Identity Security

  • Board Member

    2022

    Fraud and Risk Management

DataVisor is a fraud detection company powered by transformational AI technology.

Raised $94,500,000.00 from TruStage Ventures, NewView Capital, Brighton Park Capital and GSR Ventures.

  • Board Observer

    2021

    Data Science, Open Source Software

Posit is an open-source data science company the individual, team and enterprise.

  • Board Member

    2024

    TASE:GLBX - User Experience Analytics

  • Investor

    2020 - 2024

  • Investor

    2021

    Data Management

Reltio provides a cloud-native, SaaS data platform that synthesizes multi-source, complex data into a single source of trusted information.

Raised $237,000,000.00 from .406 Ventures, NewView Capital, RPS Ventures, Brighton Park Capital, Sapphire Ventures and Crosslink Capital.

  • Investor

    2021

    Pharma and Biopharma Commercialization

Indegene enables global health care organizations address complex challenges and drive better health and business outcomes.

Raised $200,000,000.00 from Carlyle Global Partners and Brighton Park Capital.

  • Associate

    2017 - 2019

Berkshire Partners invests in mid-size private companies through seven funds with aggregate capital commitments.

  • Senior Associate Consultant

    2014 - 2017

Articles About Tim

Relevant Websites